A Study to Determine the Feasibility of Online Recruitment of People Using an Anti-Obesity Medication for Weight Loss

CompletedOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

November 14, 2024

Primary Completion Date

January 6, 2025

Study Completion Date

January 6, 2025

Conditions

Obesity

Interventions

DEVICE

TAP® Micro Select Device (Touch Activated Phlebotomy)

The TAP Micro Select device will be used in an investigational capacity by participants for self-collection of whole capillary blood.

Trial Locations (1)

YourBio Health/CRT, Medford